Characteristic expression profiles induced by genotoxic carcinogens in rat liver

Toxicological Sciences

Volumn 77, Issue 1, 2004, Pages 19-34

  Ellinger Ziegelbauer, Heidrun ^a   Stuart, Barry ^b   Wahle, Brad ^b   Bomann, Werner ^b   Ahr, Hans Jürgen ^a  

^a BAYER AG   (Germany)

^b BAYER CORPORATION   (United States)

Author keywords

Characteristic profiles; Genotoxic carcinogens; Microarray; Rat liver; Toxicogenomics

Indexed keywords

2 NITROFLUORENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; AFLATOXIN B1; CARCINOGEN; DIMETHYLNITROSAMINE; DNA; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOASSAY; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TARGETING; GENETIC REGULATION; GENETIC TOXICOLOGY; GENOTOXICITY; IN VIVO STUDY; INFLAMMATION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER TUMOR; MALE; MEDICAL INSTRUMENTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; RAT; REVIEW; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; VALIDATION PROCESS;

ANIMALS; CARCINOGENS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; TOXICOGENETICS;

ANIMALIA;

EID: 1642504808     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh016     Document Type: Review

References (77)

1. Amundson, S. A., Bittner, M., Meltzer, P., Trent, J., and Fornace, A. J., Jr. (2001). Physiological function as regulation of large transcriptional programs: The cellular response to genotoxic stress. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 129, 703-710.
2. Bone-Larson, C. L., Hogaboam, C. M., Evanhoff, H., Strieter, R. M., Kunkel, S. L. (2001). IFN-γ-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J. Immunol. 167(12):7077-7083.
3. Bouton, C. M. L. S., Hossain, M. A., Frelin, L. P., Laterra, J., and Pevsner, J. (2001). Microarray analysis of differential gene expression in lead-exposed astrocytes. Toxicol. Appl. Pharmacol. 176, 34-53.
4. Brown, T. L., Patil, S., Cianci, C. D., Morrow, J. S., and Howe, P. H. (1999). Transforming growth factor β induces caspase 3-independent cleavage of αII-spectrin (α-fodrin) coincident with apoptosis. J. Biol. Chem. 274, 23256-23262.
5. Broxterman, H. J., Giaccone, G., and Lankelma, J. (1995). Multidrug resistance proteins and other drug transport-related resistance to natural product agents. Curr. Opin. Oncol. 7, 532-540.
6. Canoll, P. D., Musacchio, J. M., Hardy, R., Reynolds, R., Marchionni, M. A., and Salzer, J. L. (1996). GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17, 229-243.
7. Cui, X. S., Torndal, U. B., Eriksson, L. C., and Moller L. (1995). Early formation of DNA adducts compared with tumor formation in a long-term tumor study in rats after administration of 2-nitrofluorene. Carcinogenesis 16, 2135-2141.
8. Fielden, M. R., and Zacharewski, T. R. (2001). Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol. Sci. 60, 6-10.
9. Fountoulakis, M., de Vera, M.-C., Crameri, F., Boess, F., Gasser, R., Albertini, S., and Suter, L. (2002). Modulation of gene and protein expression by carbon tetrachloride in the rat liver. Toxicol. Appl. Pharmacol. 183, 71-80.
10. Fritz, G., and Kaina, B. (2001). Transcriptional activation of the small GTPase gene rhoB by genotoxic stress is regulated via a CCAAT element. Nucleic Acids Res. 29, 792-798.
11. Ganger, D. R., Hamilton, P. D., Klos, D. J., Jakate, S., McChesney, L., and Fernandez-Pol, J. A. (2001). Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. Cancer Detect. Prev. 25, 231-236.
12. Gerke, V., and Moss, S. E. (2001). Annexins: From structure to function. Physiol. Rev. 82, 331-371.
13. Glaichenhaus, N., and Cuzin, F. (1987). A role for ID repetitive sequences in growth- and transformation-dependent regulation of gene expression in rat fibroblasts. Cell 50, 1081-1089.
14. Grombacher, T., Eichhorn, U., and Kaina, B. (1998). p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene 20, 845- 851.
15. Haglund, J., Henderson, A. P., Golding, B. T., Tornqvist, M. (2002). Evidence for phosphate adducts in DNA from mice treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Chem. Res. Toxicol. 15, 773-779.
16. Hamadeh, H. K., Bushel, P. R., Jayadev, S., DiSorbo, O., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J. C., Paules, R. S., Blanchard, K., and Afshari, C. A. (2002a). Prediction of compound signature using high density expression profiling. Toxicol. Sci. 67, 232-240.
17. Hamadeh, H. K., Bushel, P. R., Jayadev, S., Martin, K., DiSorbo, O., Siebert, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J. C., Blanchard, K., Paules, R. S., Blanchard, K., and Afshari, C. A. (2002b). Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67, 219-231.
18. Hayes, J. D, and McMahon, M. (2001). Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174, 103-113.
19. Hecht, S. S., Chen, C. B., Ohmori, T., and Hoffmann, D. (1980). Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butatione. Cancer Res. 40, 298-302.
20. Hoover, H. E., Thuerauf, D. J., Martindale, J. J., and Glembotski, C. C. (2000). Alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38. A potential role for α B-crystallin as a target of the p38 branch of the cardiac stress response. J. Biol. Chem. 275, 23825-23833.
21. International Agency for Research on Cancer. (1978). IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some N-Nitroso compounds. 17, 136 pp. Lyon, France.
22. International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
23. Iwaki, T., Iwaki, A., Tateishi, J., and Goldman, J. E. (1994). Sense and antisense modification of glial α B-crystallin production results in alterations of stress fiber formation and thermoresistance. J. Cell Biol. 125, 1385-1393.
24. Kannan, K., Amariglio, N., Rechavi, G., Jakob-Hirsch, J., Kela, I., Kaminski, N., Getz, G., Domany, E., and Givol, D. (2001). DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20, 2225-2234.
25. Kelly, V. P., Ellis, E. M., Manson, M. M., Chanas, S. A., Moffat, G. J., McLeod, R., Judah, D. J., Neal, G. E., and Hayes, J. D. (2000). Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Cancer Res. 60, 957-969.
26. Kitagawa, T. (1976). Sequential phenotypic changes in hyperplastic areas during hepatocarcinogenesis in the rat. Cancer Res. 36(7 Pt 2), 2534-2539.
27. Kondoh, N., Schweinfest, C. W., Henderson, K. W., and Papas, T. S. (1992). Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res. 52, 791-796.
28. Martin-Castellanos, C., and Moreno, S. (1997). Recent advances on cyclins, CDKs, and CDK inhibitors. Trends Cell. Biol. 7, 95-98.
29. Matthaei, K. I., and Williams, J. F. (1987). Ornithine aminotransferase turnover in host tissues of tumor-bearing rats. J. Natl. Cancer Inst. 79, 805-809.
30. Maurer, D., Fiebiger, E., Reininger, B., Ebner, C., Petzelbauer, P., Shi, G. P., Chapman, H. A., and Stingl, G. (1998). Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J. Immunol. 161, 2731-2739.
31. Mouse Genome Sequencing Consortium. (2002). Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-573.
32. Muller, M. (2000). Transcriptional control of hepatocanalicular transporter gene expression. Semin. Liver. Dis. 20, 323-337.
33. Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Nagase, H., Arthur, M. J., Benyon, C., and Iredale, J. P. (2002). Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: Implications for reversibility of liver fibrosis. J. Biol. Chem. 277, 11069-11076.
34. Naciff, J. M., Jump, M. L., Torontali, S. M., Carr, G. J., Tiesman, J. P., Overmann, G. J., and Daston, G. P. (2002). Gene expression profile induced by 17α-ethinyl estradiol, bisphenol a, and genistein in the developing female reproductive system of the rat. Toxicol. Sci. 68, 184-199.
35. Naciff, J. M., Overmann, G. J., Torontali, S. M., Carr, G. J., Tiesman, J. P., Richardson, B. D., and Daston, G.P. (2003). Gene expression profile induced by 17α-ethinyl estradiol in the prepubertal female reproductive system of the rat. Toxicol. Sci. 72, 314-330.
36. Nakano, T., Kawamoto, K., Higashino, K., and Arita, H. (1996). Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett. 387, 78-80.
37. Neal, G. E., and Legg, R. F. (1983). The ineffectiveness of reduced glutathione in preventing the development of liver tumours from aflatoxin-induced pre-neoplastic liver lesions. Cancer Lett. 21, 83-87.
38. Ohsawa, K., Imai, Y., Kanazawa, H., Sasaki, Y., and Kohsaka, S. (2000). Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell. Sci. 113, 3073-3084.
39. Ozeki, A., and Tsukamoto, I. (1999). Retinoic acid repressed the expression of c-fos and c-jun and induced apoptosis in regenerating rat liver after partial hepatectomy. Biochim. Biophys. Acta 1450, 308-319.
40. Pappas, P., Stephanou, P., Vasiliou, V. L., and Marselos, M. (1998). Anti-inflammatory agents and inducibility of hepatic drug metabolism. Eur. J. Drug Metab. Pharmacokinet. 23, 457-460.
41. Paradiso, A., Simone, G., Petroni, S., Leone, B., Vallejo, C., Lacava, J., Romero, A., Machiavelli, M., De Lena, M., Allegra, C. J., and Johnston, P. G. (2000). Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br. J. Cancer 82, 560-567.
42. Parkinson, A. (2001). Biotransformation of xenobiotics. In Casarett & Doull's Toxicology, 6th ed. (C. D. Klaassen, Ed.), pp. 133-224. McGraw-Hill, New York.
43. Pegg, A. E. (1984). Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest. 2, 223-231.
44. Pennie, W. D., and Kimber, I. (2002). Toxicogenomics: Transcript profiling and protential application to chemical allergy. Toxicol. In Vitro 16, 319-326.
45. Pitot III, H. C., and Dragon, Y. P. (2001). Chemical carcinogenesis. In Casarett & Doull's Toxicology, 6th ed. (C. D. Klaassen, Ed.), pp. 241-319. McGraw-Hill, New York.
46. Prendergast, G. C. (2001). Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiology. Histol. Histopathol. 16, 269-275.
47. Rat Genome Sequencing Consortium. (2002). Available at http://www.hgsc.bcm.tmc.edu/projects/rat/
48. Reynolds, E. S. (1972). Comparison of early injury to liver endoplasmic reticulum by halomethanes, hexachloroethane, benzene, toluene, bromobenzene, ethionine, thioacetamide, and dimethylnitrosamine. Biochem. Pharmacol. 21, 2555-2561.
49. Robinson, D. (1998). The International Life Science Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Pathol. 26, 474-475.
50. Rushmore, T. H., and Kong, A. N. (2002). Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug. Metab. 3, 481-490.
51. Russell, A. C., Bekkedai, M. Y.-V., Mann, T. T., Ritchie, G. D., Rossi, J. III, Stenger, D. A., Pancrazio, J. J., and Andreadis, J. D. (2002). Gene modulation in total brain induced by exposure to the bicyclic phosphorus ester trimethylolpropane phosphate (TMPP). Neurotoxicology 23, 215-221.
52. Santelli, G., Califano, D., Chiappetta, G., Vento, M. T., Bartoli, P. C., Zullo, F., Trapasso, F., Viglietto, G., and Fusco, A. (1999). Thymosin β-10 gene overexpression is a general event in human carcinogenesis. Am. J. Pathol. 155, 799-804.
53. Sato, M., and Kondoh, M. (2002). Recent studies on metallothionein: Protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 196, 9-22.
54. Shultz, V. D., Phillips, S., Sar, M., Foster, P. M., and Gaido, K. W. (2001). Altered gene profiles in fetal rat testes after in utero exposure to di(n-butyl) phthalate. Toxicol. Sci. 64, 233-242.
55. Sills, R. C., French, J. E., and Cunningham, M. L. (2001). New models for assessing carcinogenesis: An ongoing process. Toxicol. Lett. 120, 187-198.
56. Simon, S., Roy, D., and Schindler, M. (1994). Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. USA 91, 1128-1132.
57. Storck, T., von Brevern, M.-C., Behrens, C. K., Scheel, J., and Bach, A. (2002). Transcriptomics in predictive toxicology. Curr. Opin. Drug Disc. Develop. 5, 90-97.
58. Subramaniam, S., Strelau, J., and Unsicker, K. (2003). Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. J. Biol. Chem. 278, 8904-8912.
59. Teeter, L. D., Estes, M., Chan, J. Y., Atassi, H., Sell, S., Becker, F. F., and Kuo, M. T. (1993). Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol. Carcinog. 8, 67-73.
60. Thomas, R. S., Rank, D. R., Penn, S. G., Zastrov, G. M., Hayes, K. R., Pande, K., Glover, E., Silander, T., Craven, M., Reddy, J. K., et al. (2001). Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60, 1189-1194.
61. Ulrich, R., and Friend, S. H. (2002) Toxicogenomics and drug discovery: Will new technologies help us to produce better drugs? Nat. Rev. Drug Discov. 1, 84-88.
62. Uto, H., Ido, A., Moriuchi, A., Onaga, Y., Nagata, K., Onaga, M., Tahara, Y., Hori, T., Hirono, S., Hayashi, K., and Tsubouchi, H. (2001). Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells. Cancer Res. 61, 4779-4783.
63. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001). The sequence of the human genome. Science 291, 1304 -1351.
64. Vogelstein, B., Lane, D., and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
65. Wallin, A., Zhang, G., Jones, T. W., Jaken, S., and Stevens, J. L. (1992). Mechanism of the nephrogenic repair response. Studies on proliferation and vimentin expression after 35S-1,2-dichlorovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab. Invest. 66, 474-484.
66. Wang, L., Wu, Q., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P., Greene, J. R., Wang, Y., Pickett, C. B., and Liu, S. (2001). Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276, 43604-43610.
67. Waring, J. F., Gum, R., Morfitt, D., Jolly, R. A., Ciurlionis, R., Heindel, M., Gallenberg, L., Buratto, B., and Ulrich, R. G. (2002). Identifying toxic mechanisms using DNA microarrays: Evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 181-182, 537-550.
68. Watanabe, M., Matsuoka, A., Yamazaki, N., Hayashi, M., Deguchi, T., Nohmi, T., Sofuni, T. (1994). New sublines of Chinese hamster CHL stably expressing human NAT1 or NAT2 N-acetyltransferases or Salmonella typhimurium O-acetyltransferase: Comparison of the sensitivities to nitroarenes and aromatic amines using the in vitro micronucleus test. Cancer Res. 54, 1672-1677.
69. White, L. C., Wright, K. L., Felix, N. J., Ruffner, H., Reis, L. F., Pine, R., and Ting, J. P. (1996). Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. Immunity 5, 365-376.
70. Wierckx, F. C., Wedzinga, R., Meerman, J. H., and Mulder G. J. (1990). Bioactivation of 2-nitrofluorene to reactive intermediates that bind covalently to DNA, RNA, and protein in vitro and in vivo in the rat. Carcinogenesis 11, 27-32.
71. Wild, C. P., Garner, R. C., Montesano, R., and Tursi, F. (1986). Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis 7, 853-858.
72. Winter, A., and Bornemann, A. (1999). NCAM, vimentin, and neonatal myosin heavy chain expression in human muscle diseases. Neuropathol. Appl. Neurobiol. 25, 417-424.
73. Xie, W., Yeuh, M. F., Radominska-Pandya, A., Saini, S. P., Negishi, Y., Bottroff, B. S., Cabrera, G. Y., Tukey, R. H., and Evans, R. M. (2003). Control of steroid, heme, and carcinogen metabolism by nuclear pregnane x receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. USA 100, 4150-4155.
74. Yoon, H., Liyanarachchi, S., Wright, F. A., Davuluri, R., Lockman, J. C., de la Chapelle, A., and Pellegata, N. S. (2002). Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc. Natl. Acad. Sci. USA 99, 15632-15637.
75. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., and Levine, A. J. (2000). Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes. Dev. 14, 981-993.
76. Zhao, Y. Y., Sawyer, D. R., Baliga, R. R., Opel, D. J., Han, X., Marchionni, M. A., and Kelly, R. A. (1998). Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J. Biol. Chem. 273, 10261-10269.
77. Zhou, B. B., and Elledge, S. J. (2000). The DNA damage response: Putting checkpoints in perspective. Nature 408, 433-439.